Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment

by Klaudia Berk, Wiktor Bzdega, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, Hubert Zywno, Adrian Chabowski
Published 2021-01-01

Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?

by Tomasz Charytoniuk, Hubert Zywno, Karolina Konstantynowicz-Nowicka, Klaudia Berk, Wiktor Bzdega, Adrian Chabowski
Published 2020-06-01

Cannabidiol – A phytocannabinoid that widely affects sphingolipid metabolism under conditions of brain insulin resistance

by Tomasz Charytoniuk, Klaudia Sztolsztener, Ewa Harasim-Symbor, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka
Published 2021-10-01

Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?

by Krzysztof Drygalski, Klaudia Berk, Tomasz Charytoniuk, Nicoletta Iłowska, Bartłomiej Łukaszuk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka
Published 2017-11-01